Sign Up to like & get
recommendations!
2
Published in 2022 at "Reviews in medical virology"
DOI: 10.1002/rmv.2358
Abstract: SARS-CoV-2 virus has infected nearly 300 M people worldwide and has been associated with over 6 M deaths by March 2022. Since the virus emergence in December 2019 in Wuhan, several new mutations have been described. The…
read more here.
Keywords:
number;
new sars;
omicron new;
sars cov ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Nature"
DOI: 10.1038/s41586-024-07575-x
Abstract: The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited1. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics…
read more here.
Keywords:
sars cov;
cov challenge;
response;
infection ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "JCI insight"
DOI: 10.1172/jci.insight.157393
Abstract: SARS-CoV-2 has resulted in over 450 million confirmed cases since 2019. Although several vaccines have been certified by World Health Organization and are being vaccinated on a global scale, it has been reported that multiple…
read more here.
Keywords:
immunity;
k18 hace2;
sars cov;
cov challenge ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.801799
Abstract: The tuberculosis vaccine, Bacille Calmette-Guerin (BCG), also affords protection against non-tuberculous diseases attributable to heterologous immune mechanisms such as trained innate immunity, activation of non-conventional T-cells, and cross-reactive adaptive immunity. Aerosol vaccine delivery can target…
read more here.
Keywords:
cov challenge;
disease;
bcg vaccination;
sars cov ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Viruses"
DOI: 10.3390/v16030417
Abstract: The sudden emergence of SARS-CoV-2 demonstrates the need for new vaccines that rapidly protect in the case of an emergency. In this study, we developed a recombinant MVA vaccine co-expressing SARS-CoV-2 prefusion-stabilized spike protein (ST)…
read more here.
Keywords:
sars cov;
sars vaccination;
mva sars;
cov challenge ... See more keywords